United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 9,500 common shares for $4.9 million
UTHR•Option exercise and share sales reported
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercise and share sales on Aug. 3, 2026.
- A family trust acquired 9,500 common shares via option exercise at USD 135.42.
- The trust sold 9,500 common shares at weighted-average prices ranging from USD 514.83 to USD 518.61.
- Trust-held common shares fell to 324,443 following the transactions.
- Trust-held stock options totaled 217,910 after the exercise.
